Company / SG&A Expense
Phibro Animal Health SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$289.5M
FY2025
5-year range
$196.5M / $289.5M
FY2021-FY2025
Trend
+11.4%
vs FY2024
Sector context
#55 of 213
Health Care
What the data says
At $289M, Phibro Animal Health's sg&a expense ranks #159 of 213 in the Health Care sector. SG&A Expense has fluctuated over the past 10 years, ranging from $150M in FY2017 to $289M in FY2025.
Based on SEC 10-K filings.
$289M in FY2025 with a 5-year CAGR of +9.1%.
Increased from $197M to $289M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +11.9%
- 5-Year CAGR
- +9.1%
- 10-Year CAGR
- -
Sector benchmark
#159 of 213 in Health CareTop 74% of 213This company $289.5M Sector average $722.3M
▼
-59.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 11.4% year-over-year.
- Ranks #55 out of 213 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2017.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $289.5M | +11.4% |
| FY2024 | $259.8M | +32.2% |
| FY2023 | $196.5M | -4.8% |
| FY2022 | $206.4M | +5.0% |
| FY2021 | $196.5M | +4.7% |
| FY2020 | $187.7M | +3.5% |
| FY2019 | $181.4M | +18.3% |
| FY2018 | $153.3M | +2.0% |
| FY2017 | $150.3M | -1.9% |
| FY2016 | $153.3M | +25.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026